DG3173 (somatoprim), a unique somatostatin receptor subtypes 2-, 4- and 5-selective analogue, effectively reduces GH secretion in human GH-secreting pituitary adenomas even in Octreotide non-responsive tumours

Guidelines for the treatment of growth hormone excess and growth hormone deficiency in adults

(2014) A. Giustina et al.   JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION

Reassessment of sst5 Somatostatin Receptor Expression in Normal and Neoplastic Human Tissues Using the Novel Rabbit Monoclonal Antibody UMB-4

(2011) Amelie Lupp et al.   NEUROENDOCRINOLOGY

Pasireotide (SOM230) Demonstrates Efficacy and Safety in Patients with Acromegaly: A Randomized, Multicenter, Phase II Trial

(2010) S. Petersenn et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

Somatotroph Tumor Progression during Pegvisomant Therapy: A Clinical and Molecular Study

(2010) M. Marazuela et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

Pasireotide and Octreotide Stimulate Distinct Patterns of sst2ASomatostatin Receptor Phosphorylation

(2010) Florian Pöll et al.   MOLECULAR ENDOCRINOLOGY

Surgical treatment of pituitary tumours

(2009) Michael Buchfelder et al.   BEST PRACTICE & RESEARCH CLINICAL ENDOCRINOLOGY & METABOLISM

Medical Therapy of Acromegaly

(2009) Richard A. Feelders et al.   DRUGS

The German ACROSTUDY: past and present

(2009) M Buchfelder et al.   EUROPEAN JOURNAL OF ENDOCRINOLOGY

ACROSTUDY: Status Update on 469 Patients

(2009) Thierry Brue   Hormone Research in Paediatrics

Effects of Somatostatin Analogs on Glucose Homeostasis: A Metaanalysis of Acromegaly Studies

(2009) Gherardo Mazziotti et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

The clinical–molecular interface of somatostatin, dopamine and their receptors in pituitary pathophysiology

(2009) Diego Ferone et al.   JOURNAL OF MOLECULAR ENDOCRINOLOGY

Acromegaly: correlation between expression of somatostatin receptor subtypes and response to octreotide-lar treatment

(2009) Ana Paula M. Casarini et al.   Pituitary

Somatostatin Receptor sst2 Decreases Cell Viability and Hormonal Hypersecretion and Reverses Octreotide Resistance of Human Pituitary Adenomas

(2008) J. Acunzo et al.   CANCER RESEARCH

Pegvisomant increases intra-abdominal fat in patients with acromegaly: a pilot study.

(2008) U Plöckinger et al.   EUROPEAN JOURNAL OF ENDOCRINOLOGY

Quantitative analysis of somatostatin receptor subtypes (1–5) gene expression levels in somatotropinomas and correlation to in vivo hormonal and tumor volume responses to treatment with octreotide LAR

(2008) Giselle F Taboada et al.   EUROPEAN JOURNAL OF ENDOCRINOLOGY

Reassessment of sst2Somatostatin Receptor Expression in Human Normal and Neoplastic Tissues Using the Novel Rabbit Monoclonal Antibody UMB-1

(2008) Thomas Fischer et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

Selective Loss of Somatostatin Receptor 2 in Octreotide-Resistant Growth Hormone-Secreting Adenomas

(2008) Ursula Plöckinger et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

Function and expression of somatostatin receptors of the endocrine pancreas

(2008) Mathias Z. Strowski et al.   MOLECULAR AND CELLULAR ENDOCRINOLOGY

Dimerization of G protein-coupled receptors: New avenues for somatostatin receptor signalling, control and functioning

(2007) Mario Durán-Prado et al.   MOLECULAR AND CELLULAR ENDOCRINOLOGY

Somatostatin agonists for treatment of acromegaly

(2007) Anat Ben-Shlomo et al.   MOLECULAR AND CELLULAR ENDOCRINOLOGY

Pasireotide (SOM230): Development, mechanism of action and potential applications

(2007) Herbert A. Schmid   MOLECULAR AND CELLULAR ENDOCRINOLOGY